Clinical Trial Update: Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PN 200 or Naproxen in Subjects Who Are at Risk for Developing NSAID-Associated Ulcers. [Phase 3]

View source ↗

Summary

A completed Phase 3 trial compared PN 200 with naproxen to evaluate the incidence of gastric ulcers in subjects at risk for NSAID-associated ulcers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Osteoarthritis
• Rheumatoid Arthritis

Drugs mentioned

• Naproxen (Naproxen)
• PN 200

Snippet

Sponsor: POZEN | Conditions: Osteoarthritis, Rheumatoid Arthritis | Phase 3 | Status: COMPLETED